GlassScriptPhysician profile
Rabih Kashouty
NPI 1487946539
$34,049.53
in general payments reported to CMS, 2019-2025
69 companies · $6,812 in 2025
The $6,812 reported for 2025 was more than what 86% of Clinical Neurophysiology providers received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $3,586 · 2021: $2,555 · 2022: $3,079 · 2023: $2,236 · 2024: $2,158 · 2025: $6,812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,206 · Consulting Fee: $5,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,205.79 |
| Consulting Fee | $5,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $10,957.27 | 2019-2025 | Ultomiris, Soliris |
| Pfizer INC. | $5,668.40 | 2021-2025 | |
| Abbvie INC. | $2,145.72 | 2019-2025 | |
| Merz North America, INC. | $1,209.44 | 2019-2022 | |
| Allergan, INC. | $1,194.90 | 2019-2022 | |
| Biogen, INC. | $1,058.02 | 2019-2024 | Vumerity, Tysabri, Plegridy |
| Ucb, INC. | $904.24 | 2019-2025 | Zilbrysq, Briviact, Nayzilam |
| Acadia Pharmaceuticals INC | $713.10 | 2019-2025 | Nuplazid |
| Zyla Life Sciences, INC. | $612.55 | 2019-2020 | |
| Argenx US, INC. | $574.76 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Sunovion Pharmaceuticals INC. | $535.00 | 2019-2022 | |
| Eisai INC. | $533.64 | 2019-2025 | |
| Mdd US Operations, LLC | $488.07 | 2019-2024 | Apokyn, Apokyn, Gocovri |
| Teva Pharmaceuticals USA, INC. | $470.65 | 2019-2024 | Austedo Xr, Austedo |
| Kyowa Kirin, INC. | $370.29 | 2020-2024 | Nourianz |
Show all 69 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rabih Kashouty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.